PKU is a metabolic disorder caused by a deficiency of the liver enzyme phenylalanine hydroxylase Phenyalanine to Tyrosine
Fig. 1. A drop of blood is spotted onto a sample card, and an aliquot is extracted for analysis by MS or GC-MS. The peak profile is used to diagnose metabolic errors.
6
Amino acids extraction 200 L methanol/HCl 0.1% in a screw cap vial, 1 h, at 4C or by sonication for 1 min. 100 L of the extract placed in a vial, Addition of the internal standard and removing of the reagent ina nitrogen stream
AA derivatization
Esterification: 500 Lbutanol: acetyl chloride, 4:1 (v/v), 30 min, at 100C. The excess reagent is removed with a stream of nitrogen
7
Analytical instrument : Trace DSQ ThermoFinnigan quadruple mass spectrometer Trace GC. Column capillary column Rtx-5ms 30 m 0.25 mm, 0.25 m TC Prog. : : 50 C (1 min) to 310 C, at 20 C/min. Carrier gas : Helium (99.9995%) Flow rate : 1 mL/min
Fig. 2. The mass spectra of the phenylalanine and tyrosine as trifluoroacetic butyl ester derivatives used for PKU diagnosis
9
The fingerprint chromatograms in SIM-GC-MS for a PKU patient (our results) present the differences between the first (top chromatogram) and the third month of treatment (second chromatogram) . The retention times for the amino acids: 15N-Gly at 6.40 min, Val at 7.02 min, Leu at 7.50 min, Pro at 8.40 min, Phe at 9.70 min and Tyr at 11.28 min. 10
PKU diagnosis could be tested by calculating the ratio Phe/Tyr using 20 L of blood spots. A comparison of two chromatograms demonstrates the benefit of the treatment in the case of a PKU child . The first fingerprint chromatogram presents higher intensity of the phenylalanine peak in the case of a patient presenting PKU, and after three months of treatment the peak of Phe is significantly decreased. The ratio of Phe/Tyr decreased from 2.30 at 1.02.
11
Why LC-MS/MS?
12
13
Analysis:
- Sample preparation Derivatization by N,N-Dimethyl glycine -LC-MS/MS APCI MRM scan Mode
15
What is SELDI-TOF MS ?
16
Take 1-3 l serum sample Spot sample on the activated protein chip array
17
18
19
20
Detection of the current status of diabetic nephropathy of diabetic patients. Differentiation between patients with diabetes mellitus and healthy controls in general. Evaluation of CE-MS-defined patterns derived from urinary polypeptides of patients with diabetic nephropathy differ from those of patients with other chronic renal diseases.
21
Validation of the treatment success of drugs, like candesartan in context of diabetic nephropathy
22
Analogue insulin.
Human insulin
24
Planar chromatography is well suited for peptide analysis. Analysis of intact proteins. Simple to medium complex mixtures. Peptides from tryptic digest can be separated by HPTLC and analyzed by MS.
25
Human insulin
Bovine insulin
26
HPTLC silica gel Si 60 F254 20 10 cm. Automated TLC Sampler 4 Band length :- 5 mm Track distance :-10 mm Application volume :- 5 micro litre.
27
1452,6680[M+4H]
1936,5513[M+3H]
1445,1658[M+4H]
1926,5491[M+3H]
1434,1584[M+4H]
1912,2065[M+3H]
28
Provide rapid, comprehensive, multi-component analyses Maintain or improve sensitivity, selectivity, and accuracy Replacing many older traditional techniques
29
THANK YOU
30